TrialNutrients2020
Galacto-Oligosaccharide RP-G28 Improves Multiple Clinical Outcomes in Lactose-Intolerant Patients.
William Chey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
12 papers cite it
this papertrialcites it
TrialNutrients2020
William Chey et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.